Skip to content
★ Sign in to follow
ZJ

Zhong Ji Longevity Science Group Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$308.8MHealth Care

No insider purchase over the last 90 days. The latest, by Yan Li, was filed 23 Jul 2025.

Zhong Ji Longevity Science Group Ltd.: what insiders have been doing

Zhong Ji Longevity Science Group Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. Zhong Ji Longevity Science Group Ltd. has had no insider filing for more than a year; the last one goes back to 23 July 2025.

Over the whole record (from 2020), the tally stands at 5 purchases and 5 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from HKEX disclosures alone and does not predict where the share price will go.

Insider Decl.
13
Thresholds
n/a
Buy Volume
€54M
5 ops. · all time
Sell Volume
€2M
5 ops. · all time

Who traded when

BuySale
Yan Li1 buy

Since the insiders bought

  • Filed 23 Jul 2025 · 473 days ago · €2.5M
    -20.6%
    Entry HK$0.49 · Close at T+365 HK$0.38

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,605 of 26,897 companies
20.0
score / 100
Value
20
Quality
20
FCF yld-7.5%
Earn yld-5.4%
EV/EBITDA·
ROE-2.3%
Gross mgn16%
Net mgn-10%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.49
Analyst consensus
·
Income statement
RevenueHK$161.8M
Gross profitHK$26.5M16% margin
EBITDA-HK$6.4M-4% margin
Net income-HK$16.8M-7.1% margin
Valuation
P/Book0.8x
Beta0.65
Balance sheet & cash
Market capHK$308.8M
Total debtHK$5.6M
Free Cash Flow-HK$23.1M
Debt / Equity1%
Profitability & ownership
ROE-2.3%
ROA-1.9%
% insiders53.4%
% institutions0.0%
Last declaration on 23 July 2025
Declarations13 total
  • ▲
    DirectorExecutives
    23M HKD11HKEX
    45,511,628 shares@ HK$0.504.4% of flowShareXHKGHKEX:DA20250723E00649
    Canonical exit: 20 Oct 2025 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    491,435,175 sharesShareXHKGHKEX:DA20221020E00450
  • ▼
    DirectorExecutives
    509,012 HKD11HKEX
    7,420,000 shares@ HK$0.06860.1% of flowShareXHKGHKEX:DA20220907E00306
  • ▼
    DirectorExecutives
    15M HKD11HKEX
    302,510,000 shares@ HK$0.0513.3% of flowShareXHKGHKEX:DA20220627E00278
  • ▼
    DirectorExecutives
    3M HKD11HKEX
    44,370,000 shares@ HK$0.0620.6% of flowShareXHKGHKEX:DA20220627E00277
  • ▲
    DirectorExecutives
    72M HKD12HKEX
    150,000,000 shares@ HK$0.4814.1% of flowShareXHKGHKEX:DA20211109E00199
    Canonical exit: 3 Feb 2022 (T+90)
  • ▲
    DirectorExecutives
    256M HKD16HKEX
    511,705,175 shares@ HK$0.5049.7% of flowShareXHKGHKEX:DA20211102E00047
    Canonical exit: 27 Jan 2022 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    38,680,000 sharesShareXHKGHKEX:DA20210901E00386
  • ▼
    DirectorExecutives
    0HKEX
    77,000,000 sharesShareXHKGHKEX:DA20210806E00175
  • ●
    DirectorExecutives
    17M HKD19HKEX
    41,540,000 shares@ HK$0.4093100.0% of flowShareXHKGHKEX:DA20210623E00367
  • ▲
    DirectorExecutives
    50M HKD12HKEX
    77,000,000 shares@ HK$0.659.4% of flowShareXHKGHKEX:DA20210513E00198
    Canonical exit: 8 Aug 2021 (T+90)
  • ▲
    DirectorExecutives
    98M HKD13HKEX
    184,030,000 shares@ HK$0.5318.4% of flowShareXHKGHKEX:DA20210421E00323
    Canonical exit: 18 Jul 2021 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    9,200,000,000 sharesShareXHKGHKEX:DA20201118E00375

13 of 13 declarations

About Zhong Ji Longevity Science Group Ltd.

Zhong Ji Longevity Science Group Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the development of products related to longevity and health. It focuses on innovation in the life sciences sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations